Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Lipella Pharmaceuticals Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $46.84M | $46.84M - $46.84M | -$38.00M | $2.53 | 1 |
| Dec 2028 | $26.37M | $26.37M - $26.37M | -$21.39M | $0.40 | 1 |
| Dec 2027 | $608.9K | $608.9K - $608.9K | -$493.9K | -$2.18 | 1 |
| Dec 2026 | $583.7K | $583.7K - $583.7K | -$473.4K | -$17.42 | 1 |
| Dec 2025 | $559.5K | $559.5K - $559.5K | -$453.9K | -$5.20 | 1 |
| Dec 2024 | $363.0K | $363.0K - $363.0K | -$294.5K | -$7.85 | 1 |